Home » Newsletters » BioWorld

BioWorld

Sep. 15, 2000

View Archived Issues

Senomyx Raises $10M In Series B For Chemosensation Programs

Celera Signs With Proteome For 'BioKnowledge Library'

Corvas Anticoagulant Positive In Open-Label Phase II Trial

Vertex Convertible Offering Outpaces Goal, Raises $300M

Meridian Diagnostics Moves To Acquire Viral Antigens for $9M

OSI's Oral EGFR Inhibitor Positive In Early Phase II

Erythropoietin Therapy Found To Work In Cerebral Insults - Stroke, Trauma, Autoimmunity, Epilepsy

Prescription Drug Coverage Emerges As Hot-Button Issue

Other News To Note